Evidence map›Paper›PMID 32928305›Full record

ReviewStem cell research & therapy2020

Therapeutic application of adipose-derived stromal vascular fraction in diabetic foot.

Xiansheng Zhao, Jiamin Guo, Fangfang Zhang, Jue Zhang, Delin Liu, Wenjun Hu, Han Yin, Liang Jin

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xiansheng ZhaoSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China.
Jiamin GuoIrell & Manella Graduate School of Biological Sciences, City of Hope National Medical Center, California, 91010, USA.
Fangfang ZhangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China.
Jue ZhangDepartment of Endocrinology, The Affiliated ZhongDa Hospital of Southeast University, Nanjing, 210009, Jiangsu Province, China.
Delin LiuDepartment of Endocrinology, The Affiliated ZhongDa Hospital of Southeast University, Nanjing, 210009, Jiangsu Province, China.
Wenjun HuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China. wjhu@cpu.edu.cn.
Han YinDepartment of Endocrinology, The Affiliated ZhongDa Hospital of Southeast University, Nanjing, 210009, Jiangsu Province, China. yinhan789@163.com.
Liang JinSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China. ljstemcell@cpu.edu.cn.
China Pharmaceutical University · CNZhongda Hospital Southeast University · CNCity Of Hope National Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic foot is one of the severest complications of diabetes. In severe cases, this disease may be lead to amputation or even death due to secondary infection and ischemic necrosis. Since the ineffectiveness of traditional therapy, autologous stem cell transplantation has been used to treat diabetic foot. This simple, safe, and effective therapy is expected to be applied and promoted in the future.In this review, we described the detailed pathogenesis of diabetic foot and the common clinical treatments currently used. We also revealed vascular remodeling as the potential mechanism of therapeutic functions of adipose-derived stromal vascular fraction (SVF) in treating diabetic foot.

Indexed as

Diabetes MellitusDiabetic FootHematopoietic Stem Cell TransplantationAdipose TissueAmputation, SurgicalHumansStromal CellsTransplantation, AutologousCytokineDiabetic footStem cells therapyStromal vascular fraction (SVF)Vascular reconstruction

Identifiers

PMID32928305
PMCPMC7488783
OpenAlexW3084672935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.